Standout Papers

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 c... 2007 2026 2013 2019 780
  1. Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial (2007)
    Lu Zhang, Ferenc Martényi et al. Nature Medicine

Immediate Impact

4 by Nobel laureates 20 from Science/Nature 61 standout
Sub-graph 1 of 20

Citing Papers

Theranostic Fluorescent Probes
2024 Standout
Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors
2023 StandoutScience
3 intermediate papers

Works of Andreev Bv being referenced

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial
2007 Standout

Author Peers

Author Last Decade Papers Cites
Andreev Bv 596 193 134 413 29 857
A M Reznik 590 196 149 418 21 858
Philipp Singer 629 161 143 416 36 1.1k
Geoffrey Pavey 557 248 130 497 34 910
А С Аведисова 593 250 180 418 39 1.0k
Masatomo Ishikawa 319 168 141 373 27 930
Karla Drescher 598 131 76 480 30 991
Masahiro Nankai 496 204 115 312 25 921
M.D.C. Simpson 753 310 163 427 34 1.1k
Elisabetta Filomena Buonaguro 412 323 173 317 39 967
Yoko Hagino 530 82 78 301 46 764

All Works

Loading papers...

Rankless by CCL
2026